On the recordJuly 26, 2017
If I might ask one final question, would my colleague agree that rather than this approach, in which we don't even know, moment to moment, what we are voting on here--unlike what we did in the Finance Committee in 2009, where there were 100 hearings in the Finance Committee and the HELP Committee before we even voted on anything on the Affordable Care Act. Rather than that process, we are looking at a situation where everything coming before us will take away healthcare for tens of millions of people and raise costs on everyone. Would my colleague agree that it would be better to stop this process and go back to a bipartisan effort to lower costs and increase healthcare coverage? Would my colleague agree, as well, that we know that there are people paying too much for copays and premiums, and that needs to be addressed? In the private marketplace, there is not enough competition among insurance companies. In some places, there are none in the individual market. We need to work together to lower costs, starting with prescription drugs, and to also continue to increase the opportunity for people to get healthcare coverage. That is what we ought to be doing together and doing it in a thoughtful way and getting input and actually solving the real problems.





